MIPI (Mantle Cell Lymphoma International Prognostic Index) is a clinical scoring system used to estimate prognosis in patients with mantle cell lymphoma (MCL). It helps stratify patients into risk groups and supports treatment discussions and trial stratification, but it does not replace clinical judgment.
MIPI (Mantle Cell Lymphoma IPI) Calculator
Original continuous MIPI based on age, ECOG, LDH, and white blood cell count.
Clinical use only. This tool is for health professionals
as an aid to risk stratification in mantle cell lymphoma. It does not
replace clinical judgment or formal guidelines and must not be used by
patients to make treatment decisions.
Result
Enter values above and press “Calculate MIPI” to see the score and risk group.

